NCT07245134 Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients
| NCT ID | NCT07245134 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Mental Health, Czech Republic |
| Condition | Obsessive-Compulsive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 62 participants |
| Start Date | 2022-11-15 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 62 participants in total. It began in 2022-11-15 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly assigned to one of the following interventions: a) exposure condition - the group with a standard CBT program enriched with exposure therapy in VR (VRET), b) control condition 1 - the group with a standard CBT program enriched with VR cognitive training aimed at cognitive flexibility or c) control condition 2 - standard CBT program without any additional VR intervention. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11 * Fluent in Czech Exclusion Criteria: * Any other psychiatric, neurological and serious somatic illness * Substance abuse * Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics. * Contradictions to using a virtual reality (e.g., epilepsy, balance problems) * Pregnancy * Cardiostimulator and mental implants
Contact & Investigator
Iveta Fajnerová, Ph.D.
STUDY DIRECTOR
National Institute of Mental Health (NIMH)
Frequently Asked Questions
Who can join the NCT07245134 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, up to 55 Years, studying Obsessive-Compulsive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07245134 currently recruiting?
Yes, NCT07245134 is actively recruiting participants. Contact the research team at Iveta.fajnerova@nudz.cz for enrollment information.
Where is the NCT07245134 trial being conducted?
This trial is being conducted at Klecany, Czechia.
Who is sponsoring the NCT07245134 clinical trial?
NCT07245134 is sponsored by National Institute of Mental Health, Czech Republic. The principal investigator is Iveta Fajnerová, Ph.D. at National Institute of Mental Health (NIMH). The trial plans to enroll 62 participants.